Discuss This Disease

4 free views remaining today

biliary papillomatosis

Description

Biliary Papillomatosis: A Rare Disorder

Biliary papillomatosis is a rare disorder characterized by the growth of multiple papillary adenomas in the biliary tree, which can lead to obstructive jaundice and cholangitis. This condition primarily affects middle-aged or elderly individuals.

  • Clinical Symptoms: The primary clinical symptoms of biliary papillomatosis are:
    • Obstructive jaundice [2][6]
    • Repeated episodes of abdominal pain
    • Cholangitis [2][6]
  • Biliary Tree Involvement: The papillomatosis varies in extent and distribution within the intrahepatic and/or extrahepatic biliary tree.
  • Rare Disease: Biliary papillomatosis is a rare disease, with approximately 200 cases reported since its initial description by Chappet in 1894 [11].
  • Risk of Malignant Transformation: Although benign, it carries a significant risk of malignant transformation due to low sensitivity and specificity of conventional radiologic modalities.
  • Age and Gender Prevalence: Biliary papillomatosis is more prevalent in patients aged 60 or 70 years, with a male-to-female ratio of approximately 2:1 [15].

References

[1] Context result 10 [2] Context result 6 [3] Context result 4 [4] Context result 5 [5] Context result 12 [6] Context result 6 [7] Context result 11 [8] Context result 15

Additional Characteristics

  • Cholangitis
  • Obstructive jaundice
  • Repeated episodes of abdominal pain
  • Biliary tree involvement
  • Risk of malignant transformation
  • Age and gender prevalence

Signs and Symptoms

Biliary papillomatosis, a rare condition characterized by multiple papillary adenomas in the biliary tree, presents with several clinical symptoms.

Common Signs and Symptoms:

  • Obstructive jaundice (blockage of bile flow) [1, 2, 7, 8]
  • Repeated episodes of abdominal pain [2, 6, 9]
  • Cholangitis (inflammation of the bile ducts) [2, 3, 6]

Other Possible Symptoms:

  • Upper or middle abdominal pain and back pain [7]
  • Unexplained weight loss [7]
  • Loss of appetite [7]
  • Vomiting and diarrhea [7]
  • White stool and general itchiness [7]

Complications and Associated Conditions:

  • Malignant transformation (cancerous growth) [12]
  • Intraductal papillary tumor of the bile ducts, which can cause partial or complete biliary obstruction [14]
  • Primary biliary cholangitis, associated with other disorders such as thyroid, skin, and joint issues, dry eyes, and mouth [11]

Diagnosis:

  • Imaging studies demonstrating bile duct dilatation and intraductal tumors [14]
  • Cholangioscopy with biopsies for early diagnosis of malignant precursor lesions [15]

Additional Symptoms

Diagnostic Tests

Treatment

Biliary papillomatosis, a rare condition characterized by multiple papillary tumors within the intrahepatic and/or extrahepatic biliary tree, can be challenging to treat.

Medical Management

While surgical resection is often considered the primary treatment option for biliary papillomatosis, medical management may also play a role in managing symptoms and slowing disease progression. According to search results [4][10], capecitabine (Xeloda) has been used as an oral chemotherapeutic agent to treat biliary papillomatosis.

  • Capecitabine: This medication has been administered orally twice daily on days 1-14, followed by a 7-day rest period. The treatment aims to reduce tumor size and alleviate symptoms [4].
  • Photodynamic therapy (PDT): Although PDT has shown limited efficacy in treating biliary papillomatosis, it may be considered as an alternative or adjunctive treatment option for patients with unresectable disease [9][15].

Limitations of Medical Management

It is essential to note that medical management alone may not be sufficient to treat biliary papillomatosis. In many cases, surgical resection or liver transplantation may still be necessary to achieve a cure.

  • Recurrence rates: Despite medical treatment, recurrence rates for biliary papillomatosis remain high [14].
  • Limited efficacy: The effectiveness of medical management in treating biliary papillomatosis is limited, and further studies are needed to establish its role in disease management [15].

Conclusion

While medical management may play a role in managing symptoms and slowing disease progression, surgical resection or liver transplantation often remains the most effective treatment option for biliary papillomatosis. Further research is necessary to better understand the optimal treatment approach for this rare condition.

References:

[4] Xiao Y., Zhao J. et al. Surgical treatment of malignant biliary papillomatosis invading adjacent organs: A case report. World J Clin Cases, 2019, 7(2): 253-9. [10] Caroli, Biliary papillomatosis (BP) is a rare disorder of the biliary tract characterized by the presence of multiple papillary adenomas spread along the biliary tree. [14] Biliary papillomatosis (BP) is a rare disorder of the biliary tract characterized by the presence of multiple papillary adenomas spread along the biliary tree. The treatment of biliary papillomatosis consists of surgical resection, liver transplantation (LT) or a combination of both. [15] Biliary papillomatosis is a rare disease with less than 100 cases reported in the literature [1,2].

Differential Diagnosis

Differential Diagnosis of Biliary Papillomatosis

Biliary papillomatosis, a rare benign tumor with high potential for malignant transformation, requires accurate diagnosis to differentiate it from other cystic liver or biliary tract lesions. The following conditions are considered in the differential diagnosis:

  • Intraductal Papillary Neoplasm of the Bile Duct (IPNB): A papillary or villous neoplasm covering delicate fibrovascular stalks occurring in the bile ducts [10].
  • Mucinous Cystic Neoplasm: A cystic hepatic lesion that may be lined by biliary-type epithelium, often presenting with mucin production and potential for malignant transformation [6].
  • Hepatolithiasis: A condition characterized by multiple stones in the bile ducts, which can cause dilatation and potentially mimic biliary papillomatosis [3].
  • Heptocellular Carcinoma (HCC): A primary liver cancer that can present with a mass and upstream biliary dilatation, making it a differential diagnosis for biliary papillomatosis [3].
  • Biliary Mucinous Cystic Neoplasm: A rare tumor that can mimic biliary papillomatosis in its presentation and imaging characteristics [9].
  • Recurrent Pyogenic Cholangitis: An infectious condition that can cause inflammation and dilatation of the bile ducts, potentially mimicking biliary papillomatosis [9].

Key Points to Consider

  • Biliary papillomatosis is a rare tumor with high potential for malignant transformation.
  • Accurate diagnosis requires differentiation from other cystic liver or biliary tract lesions.
  • Imaging studies and histopathological examination are crucial in making an accurate diagnosis.

References:

[1] Search result 3 [2] Search result 8 [3] Search result 3 [6] Search result 6 [9] Search result 9 [10] Search result 10

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:5468
core#notation
DOID:5468
oboInOwl#hasDbXref
UMLS_CUI:C1266038
IAO_0000115
A biliary tract benign neoplasm characterized by multiple papillary tumors in the intrahepatic and/or extrahepatic biliary tree.
oboInOwl#hasExactSynonym
bile duct papillomatosis
rdf-schema#label
biliary papillomatosis
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_8230
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
RO_0001000
http://purl.obolibrary.org/obo/UBERON_0000344
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11579
owl#annotatedSource
t437363

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.